Document Detail


Diethylstilbestrol exposure.
MedLine Citation:
PMID:  15168959     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diethylstilbestrol is a synthetic nonsteroidal estrogen that was used to prevent miscarriage and other pregnancy complications between 1938 and 1971 in the United States. In 1971, the U.S. Food and Drug Administration issued a warning about the use of diethylstilbestrol during pregnancy after a relationship between exposure to this synthetic estrogen and the development of clear cell adenocarcinoma of the vagina and cervix was found in young women whose mothers had taken diethylstilbestrol while they were pregnant. Although diethylstilbestrol has not been given to pregnant women in the United States for more than 30 years, its effects continue to be seen. Women who took diethylstilbestrol during pregnancy have a slightly higher risk of breast cancer than the general population and therefore should be encouraged to have regular mammography. Women who were exposed to diethylstilbestrol in utero may have structural reproductive tract anomalies, an increased infertility rate, and poor pregnancy outcomes. However, the majority of these women have been able to deliver successfully. Recommendations for gynecologic examinations include vaginal and cervical digital palpation, which may provide the only evidence of clear cell adenocarcinoma. Initial colposcopic examination should be considered; if the findings are abnormal, colposcopy should be repeated annually. If the initial colposcopic examination is normal, annual cervical and vaginal cytology is recommended. Because of the higher risk of spontaneous abortion, ectopic pregnancy, and preterm delivery, obstetric consultation may be required for pregnant women who had in utero diethylstilbestrol exposure. The male offspring of women who took diethylstilbestrol during pregnancy have an increased incidence of genital abnormalities and a possibly increased risk of prostate and testicular cancer. Routine prostate cancer screening and testicular self-examination should be encouraged.
Authors:
Sarina Schrager; Beth E Potter
Related Documents :
10804489 - Continuous low-dose antibiotics and cerclage for recurrent second-trimester pregnancy l...
6856229 - Cervical pregnancy analysis: a review and report of five cases.
15042009 - Preinduction cervical ripening with the foley catheter and the risk of subsequent prete...
2274489 - Diagnosis and significance of cystic hygroma in the first trimester.
15578649 - Late or emergency (salvage) cerclage of a dilated cervix after tissue support with pelv...
2551749 - Enzymatic collagen degradation in the pregnant guinea pig cervix during physiological m...
9408259 - Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplace...
8030609 - Evaluation of effectiveness of iron-folate supplementation and anthelminthic therapy ag...
18384499 - Reduced fertility in high-yielding dairy cows: are the oocyte and embryo in danger? par...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  American family physician     Volume:  69     ISSN:  0002-838X     ISO Abbreviation:  Am Fam Physician     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-31     Completed Date:  2004-06-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1272646     Medline TA:  Am Fam Physician     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2395-400     Citation Subset:  AIM; IM    
Affiliation:
University of Wisconsin Medical School, Department of Family Medicine, Madison, Wisconsin 53715, USA. sbschrag@wisc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / chemically induced
Diethylstilbestrol / adverse effects*
Estrogens, Non-Steroidal / adverse effects*
Female
Genital Diseases, Female / chemically induced
Genital Diseases, Male / chemically induced
Humans
Male
Pregnancy
Prenatal Exposure Delayed Effects*
Chemical
Reg. No./Substance:
0/Estrogens, Non-Steroidal; 56-53-1/Diethylstilbestrol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of hyponatremia.
Next Document:  Guillain-Barré syndrome.